Why do cancer patients smoke and what can providers do about it?

Duffy, Susan; Louzon, Samantha A.; Gritz, Ellen R.

doi:10.1016/j.cmonc.2012.10.003

Cited by 44 publications

(43 citation statements)

References 82 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…( 8 , 9 , 13 - 16 , 22 ) However, in our sample, 63 patients (88.7%) ceased tobacco use. Of those, only 2 received pharmacological treatment (nicotine patch).…”

Section: Discussioncontrasting

confidence: 51%

See 1 more Smart Citation

Nicotine dependence and smoking habits in patients with head and neck cancer

Almeida

Bandeira

Gonçalves³

et al. 2014

J. bras. pneumol.

View full text Add to dashboard Cite

Objective: To assess smoking habits and nicotine dependence (ND) in patients with head and neck cancer Methods: This study involved 71 smokers or former smokers with squamous cell carcinoma in the oral cavity, pharynx, or larynx who were treated at a university hospital in the city of São Paulo between January and May of 2010. We used the Fagerström Test for Nicotine Dependence to evaluate smoking habits and ND in the sample. Data regarding cancer treatment were collected from medical records. Depending on the variables studied, we used the chi-square test, Fisher's exact test, Student's t-test, or Spearman's correlation test. Results: Of the 71 patients, 47 (66.2%) presented with high or very high ND, 40 (56.3%) smoked more than 20 cigarettes/day, and 32 (45.1%) smoked their first cigarette within 5 min of awakening. Advanced disease stage correlated significantly with the number of cigarettes smoked per day (p = 0.011) and with smoking history (p = 0.047). We found that ND did not correlate significantly with gender, disease stage, smoking cessation, or number of smoking cessation attempts, nor did the number of cigarettes smoked per day correlate with smoking cessation or gender. Treatment for smoking cessation was not routinely offered. Conclusions: In most of the patients studied, the level of ND was high or very high. The prevalence of heavy smoking for long periods was high in our sample. A diagnosis of cancer is a motivating factor for smoking cessation. However, intensive smoking cessation treatment is not routinely offered to smoking patients diagnosed with cancer.

show abstract

“…( 8 , 9 , 13 - 16 , 22 ) However, in our sample, 63 patients (88.7%) ceased tobacco use. Of those, only 2 received pharmacological treatment (nicotine patch).…”

Section: Discussioncontrasting

confidence: 51%

“…This result confirms literature reports that smoking after a cancer diagnosis is yet to be routinely addressed as a disease requiring treatment. ( 8 , 9 , 16 , 23 ) …”

Section: Discussionmentioning

confidence: 99%

Nicotine dependence and smoking habits in patients with head and neck cancer

Almeida

Bandeira

Gonçalves³

et al. 2014

J. bras. pneumol.

View full text Add to dashboard Cite

show abstract

“…In our results, the similarity in smoking rates between current cancer patients and the non-cancer patient population could be attributable to high smoking relapse rates among cancer patients despite attempts to quit immediately after a cancer diagnosis 18,19 . Alternatively, cancer patients might believe that the damage has already been done and therefore quitting might not help them 7,17 . The type of cancer diagnosis can also influence a smoker's decision to quit.…”

Section: Discussionmentioning

confidence: 99%

“…Patients with other types of cancer (for example, colorectal, breast, or prostate) might not see the link and might therefore have less motivation to quit 7,12 . Additional reasons for continued smoking include psychological stress or depression after diagnosis, lack of social support (because smokers might have family members or friends who are also smokers), sex, education, and socioeconomic status 17 .…”

Section: Discussionmentioning

confidence: 99%

“…One important explanation is that cancer diagnosis and treatment are often unappreciated by health professionals as a teachable moment for smoking cessation 3,15,16 . Cancer patients might try to quit, but are unable to do so independently or with limited support 7,17 . In our results, the similarity in smoking rates between current cancer patients and the non-cancer patient population could be attributable to high smoking relapse rates among cancer patients despite attempts to quit immediately after a cancer diagnosis 18,19 .…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Smoking Behaviours of Current Cancer Patients in Canada

et al. 2016

View full text Add to dashboard Cite

Evidence shows that continued smoking by cancer patients leads to adverse treatment outcomes and affects survival. Smoking diminishes treatment effectiveness, exacerbates side effects, and increases the risk of developing additional complications. Patients who continue to smoke also have a higher risk of developing a second primary cancer or experiencing a cancer recurrence, both of which ultimately contribute to poorer quality of life and poorer survival. Here, we present a snapshot of smoking behaviours of current cancer patients compared with the non-cancer patient population in Canada.Minimal differences in smoking behaviours were noted between current cancer patients and the rest of the population. Based on 2011-2014 data from the Canadian Community Health Survey, 1 in 5 current cancer patients (20.1%) reported daily or occasional smoking. That estimate is comparable to findings in the surveyed non-cancer patient population, of whom 19.3% reported smoking daily or occasionally. Slightly more male cancer patients than female cancer patients identified as current smokers. A similar distribution was observed in the non-cancer patient population.There is an urgent need across Canada to better support cancer patients in quitting smoking. As a result, the quality of patient care will improve, as will cancer treatment and survival outcomes, and quality of life for these patients.

show abstract

Opportunities to address lung cancer disparities among African Americans

et al. 2014

View full text Add to dashboard Cite

Race and socioeconomic status are well known to influence lung cancer incidence and mortality patterns in the U.S. Lung cancer incidence and mortality rates are higher among blacks than whites. In this article we review opportunities to address disparities in lung cancer incidence, mortality, and survivorship among African Americans. First, we summarize recent advances in the early detection and treatment of lung cancer. Then we consider black-white disparities in lung cancer treatment including factors that may contribute to such disparities; the literature on smoking cessation interventions for patients with or without a lung cancer diagnosis; and the important roles played by cultural competency, patient trust in their physician, and health literacy in addressing lung cancer disparities, including the need for culturally competent lung cancer patient navigators. Intervention efforts should focus on providing appropriate quality treatment for lung cancer and educating African Americans about the value of having these treatments in order to reduce these disparities. Culturally competent, patient navigation programs are needed that support lung cancer patients, especially socioeconomically disadvantaged patients, from the point of diagnosis to the initiation and completion of treatment, including cancer staging.

show abstract

Why do cancer patients smoke and what can providers do about it?

Cited by 44 publications

References 82 publications

Nicotine dependence and smoking habits in patients with head and neck cancer

Nicotine dependence and smoking habits in patients with head and neck cancer

Smoking Behaviours of Current Cancer Patients in Canada

Opportunities to address lung cancer disparities among African Americans

Contact Info

Product

Resources

About